CEACAM6 and pancreatic ductal adenocarcinoma: CEACAM6 was found to inhibit anoikis in the pancreatic ductal adenocarcinoma (PDA) line MiaPaca2, and inhibition of CEACAM6 with short interfering RNA (siRNA) led to decreased metastasis in a nude mouse orthotopic xenograft model [118].